Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Arienti

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Immunology|October 1, 1998
Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cellsZ Wang, F Arienti, G Parmiani, et al.
The International Journal of Biological Markers|July 1, 1992
CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytesL Rivoltini, G Cattoretti, F Arienti, et al.
European Journal of Immunology|October 1, 1995
A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytesJ Sulé-Suso, F Arienti, C Melani, et al.
Methods in Molecular Medicine|February 11, 2012
Gene therapy in melanomaG Parmiani, F Arienti, C Melani, et al.
The Journal of Clinical Investigation|June 24, 1998
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanomaD J Hicklin, Z Wang, F Arienti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administrationA Caraceni, C Martini, F Belli, et al.
International Journal of Cancer|March 12, 1991
The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotypeL Rivoltini, G Cattoretti, F Arienti, et al.
Blood|March 1, 1993
Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cellsC Gambacorti-Passerini, F Grignani, F Arienti, et al.
Human Gene Therapy|November 1, 1995
A human melanoma cell line transduced with an interleukin-4 gene by a retroviral vector releases biologically active IL-4 and maintains the original tumor antigenic phenotypeC Melani, J Sulé-Suso, F Arienti, et al.
The International Journal of Biological Markers|January 1, 1993
Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancerS Viviani, P M Salvini, P Bidoli, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Immunology|October 1, 1998
Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cellsZ Wang, F Arienti, G Parmiani, et al.
The International Journal of Biological Markers|July 1, 1992
CEA and NCA expressed by colon carcinoma cells affect their interaction with and lysability by activated lymphocytesL Rivoltini, G Cattoretti, F Arienti, et al.
European Journal of Immunology|October 1, 1995
A B7-1-transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytesJ Sulé-Suso, F Arienti, C Melani, et al.
Methods in Molecular Medicine|February 11, 2012
Gene therapy in melanomaG Parmiani, F Arienti, C Melani, et al.
The Journal of Clinical Investigation|June 24, 1998
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanomaD J Hicklin, Z Wang, F Arienti, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administrationA Caraceni, C Martini, F Belli, et al.
International Journal of Cancer|March 12, 1991
The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotypeL Rivoltini, G Cattoretti, F Arienti, et al.
Blood|March 1, 1993
Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cellsC Gambacorti-Passerini, F Grignani, F Arienti, et al.
Human Gene Therapy|November 1, 1995
A human melanoma cell line transduced with an interleukin-4 gene by a retroviral vector releases biologically active IL-4 and maintains the original tumor antigenic phenotypeC Melani, J Sulé-Suso, F Arienti, et al.
The International Journal of Biological Markers|January 1, 1993
Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancerS Viviani, P M Salvini, P Bidoli, et al.
Pageof 4